Kurt A. Gustafson's most recent trade in OmniAb Inc was a trade of 13,542 Common Stock done . Disclosure was reported to the exchange on April 7, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 13,542 | 231,034 | - | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 13,542 | 143,376 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 07 Apr 2025 | 7,206 | 223,828 | - | 2 | 14,412 | Common Stock |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 23,244 | 156,918 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 23,244 | 229,455 | - | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 01 Apr 2025 | 11,963 | 217,492 | - | 2.4 | 28,352 | Common Stock |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 337,500 | 337,500 | - | - | Stock Option (right to buy) | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 56,250 | 180,162 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 13,541 | 123,912 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 13,541 | 213,466 | - | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 16 Feb 2025 | 7,255 | 206,211 | - | 3.7 | 26,626 | Common Stock |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 27,585 | 228,246 | - | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 17 Jan 2025 | 15,526 | 212,720 | - | 3.2 | 50,304 | Common Stock |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2024 | 46,501 | 224,532 | - | - | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2024 | 46,501 | 137,453 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 07 Dec 2024 | 23,871 | 200,661 | - | 4.1 | 98,587 | Common Stock |
Xencor Inc | Kurt A. Gustafson | Director | Sale of securities on an exchange or to another person at price $ 20.68 per share. | 27 Sep 2024 | 2,503 | 9,490 (0%) | 0% | 20.7 | 51,762 | Common Stock |
Xencor Inc | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,971 | 11,971 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,986 | 11,993 (0%) | 0% | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2024 | 13,541 | 183,651 | - | - | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2024 | 13,541 | 183,954 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance and CFO | Sale of securities on an exchange or to another person at price $ 5.27 per share. | 07 Apr 2024 | 6,954 | 176,697 | - | 5.3 | 36,648 | Common Stock |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 23,254 | 197,495 | - | - | Restricted Stock Units | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 23,254 | 181,959 | - | - | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance & CFO | Sale of securities on an exchange or to another person at price $ 5.46 per share. | 01 Apr 2024 | 11,849 | 170,110 | - | 5.5 | 64,696 | Common Stock |
Xencor Inc | Kurt A. Gustafson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Kurt A. Gustafson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.73 per share. | 06 Mar 2024 | 15,000 | 20,007 (0%) | 0% | 10.7 | 160,950 | Common Stock |
Xencor Inc | Kurt A. Gustafson | Director | Sale of securities on an exchange or to another person at price $ 23.18 per share. | 06 Mar 2024 | 14,000 | 6,007 (0%) | 0% | 23.2 | 324,453 | Common Stock |
OmniAb Inc | A. Gustafson Kurt | Executive VP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 243,750 | 243,750 | - | - | Stock Option (right to buy) | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 40,625 | 220,749 | - | - | Restricted Stock Units | |
OmniAb Inc | A. Kurt Gustafson | Executive VP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 46,503 | 174,786 | - | - | Common Stock | |
OmniAb Inc | Gustafson A. Kurt | Executive VP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 46,503 | 180,124 | - | - | Restricted Stock Units | |
OmniAb Inc | A. Kurt Gustafson | Executive VP, Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.85 per share. | 07 Dec 2023 | 16,081 | 158,705 | - | 4.9 | 77,993 | Common Stock |
Xencor Inc | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 10,013 | 10,013 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 5,007 | 5,007 (0%) | 0% | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2023 | 243,750 | 243,750 | - | - | Stock Option | |
OmniAb Inc | Kurt A. Gustafson | Executive VP, Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2023 | 40,625 | 335,416 | - | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | EVP, Finance and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 01 Apr 2023 | 8,042 | 294,791 | - | 3.7 | 29,595 | Common Stock |
OmniAb Inc | Kurt A. Gustafson | EVP, Finance and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Nov 2022 | 71,174 | 0 | - | - | Stock Option | |
OmniAb Inc | Kurt A. Gustafson | EVP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 71,174 | 71,174 | - | - | Stock Option | |
OmniAb Inc | Kurt A. Gustafson | EVP, Finance and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 17,792 | 17,792 | - | 0 | Common Stock | |
OmniAb Inc | Kurt A. Gustafson | EVP, Finance and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Nov 2022 | 17,792 | 0 | - | - | Common Stock | |
Xencor Inc | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 21,412 | 21,412 | - | - | Stock Option (Right to Buy) | |
Niagen Bioscience Inc. | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 | - | - | Stock Options (right to buy) | |
Xencor Inc | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 13,953 | 13,953 | - | - | Stock Option (Right to Buy) | |
Niagen Bioscience Inc. | Kurt A. Gustafson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 20,000 | 20,000 | - | - | Stock Options (right to buy) |